Insilico signs on with CDMO Bora in $2.5B AI drug discovery deal

Red-hot generative AI specialist Insilico Medicine has teamed up with another major biopharma player, this time linking up with CDMO Bora Pharmaceuticals. | Generative AI specialist Insilico Medicine has teamed up with another biopharma company, this time CDMO Bora Pharmaceuticals. The collaboration could ultimately be worth $2.5 billion if milestones are reached.